Respiratory fluoroquinolone monotherapy versus β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A …
SH Choi, A Cesar, TAC Snow, N Saleem… - International Journal of …, 2023 - Elsevier
Introduction Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …
Respiratory fluoroquinolone monotherapy versus β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A …
SH Choi, A Cesar, TAC Snow, N Saleem… - International Journal …, 2023 - discovery.ucl.ac.uk
INTRODUCTION: Guidelines recommend respiratory fluoroquinolone monotherapy or β-
lactam plus macrolide combination therapy as first-line options for hospitalized adults with …
lactam plus macrolide combination therapy as first-line options for hospitalized adults with …
Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: a systematic …
SH Choi, A Cesar, TAC Snow, N Saleem… - 2023 - cabidigitallibrary.org
Introduction: Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild-to …
plus macrolide combination therapy as first-line options for hospitalized adults with mild-to …
Respiratory fluoroquinolone monotherapy versus β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A …
SH Choi, A Cesar, TAC Snow, N Saleem… - International Journal …, 2023 - europepmc.org
Methods We performed a systematic review and meta-analysis of randomized controlled
trials (RCTs) comparing respiratory fluoroquinolone monotherapy and β-lactam plus …
trials (RCTs) comparing respiratory fluoroquinolone monotherapy and β-lactam plus …
Respiratory fluoroquinolone monotherapy versus β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A …
SH Choi, A Cesar, TAC Snow, N Saleem… - International journal … - pubmed.ncbi.nlm.nih.gov
Introduction Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …